| Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961) |
|---|
| 11/15/2000 | CN1058487C 1,5-benzodiazepine derivatives having CCK antagoistic or agonistic activity |
| 11/09/2000 | WO2000066106A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 11/07/2000 | CA2179306C Dopamine receptor ligands |
| 11/02/2000 | WO2000064900A1 Pyrazolobenzodiazepines as cdk2 inhibitors |
| 11/01/2000 | CN1272111A Tricyclic vasopressin agonists |
| 10/26/2000 | WO2000063195A1 Novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors |
| 10/26/2000 | WO2000063186A1 Process and intermediates for preparing benzodiazepines |
| 10/25/2000 | CN1271358A Oxazolidinone derivatives and pharmaceutical compositions |
| 10/25/2000 | CN1271251A 2-methyl-thieno-benzodiazepine formulation |
| 10/24/2000 | CA2157247C Physical form of dihydro-2,3-benzodiazepine derivative |
| 10/19/2000 | WO2000061587A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 10/19/2000 | WO2000061569A1 Adamantane derivatives |
| 10/19/2000 | CA2368829A1 Adamantane derivatives |
| 10/18/2000 | EP1044023A1 A covalent conjugate of clozapine with a fatty acid and its use for treating schizophrenia |
| 10/17/2000 | US6133309 Treatment of T-helper cell type 2-mediated immune disease by retinoid antagonists |
| 10/12/2000 | CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 10/11/2000 | EP1041989A1 Novel cycloalkenyl substituted compounds |
| 10/11/2000 | EP0832075B1 n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3y l)-3-amides |
| 10/05/2000 | WO2000058294A1 Antibacterial agents |
| 10/03/2000 | US6127415 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| 10/03/2000 | US6127359 Bicyclic fibrinogen antagonists |
| 09/28/2000 | WO2000056721A1 Solid phase synthesis of benzodiazepine diones |
| 09/28/2000 | WO2000056707A1 Diaryl thioethers, compositions and uses thereof |
| 09/27/2000 | EP1038868A2 Sulfonamides as antiviral agents |
| 09/27/2000 | EP0733052B1 Bicyclene derivatives, their production and use |
| 09/27/2000 | CN1268055A Pharmaceutical suspension comprising nevirapine hemihydrate |
| 09/21/2000 | WO2000055153A1 Amide derivatives |
| 09/21/2000 | DE19912638A1 Naphthylcarbonsäureamid-substituierte Sulfonamide Naphthylcarbonsäureamid-substituted sulfonamides |
| 09/20/2000 | EP1036565A1 Preventives/remedies for diabetes |
| 09/19/2000 | US6121258 For treatment of arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 09/19/2000 | US6121256 4-(2,3-(2,5-dimethyl-2,5-hexano)dibenzo(b,f)(1,4)thiazepine-11 -yl)benzoic acid or salt |
| 09/14/2000 | WO2000053613A1 Chemical vapor deposition precursors and thermochromic materials thereof |
| 09/12/2000 | US6117940 Solid phase synthesis of compounds such as the imidazoles, benzodiazepines, pyrazines, and steroid mimics. |
| 09/12/2000 | US6117870 Cyclic amide derivatives |
| 09/12/2000 | US6117866 For inhibiting platelet aggregation or clot formation and reocclusion of an artery or vein in a mammal following fibrinolytic therapy or angioplasty; for treating stroke, transient ischemia attacks, or myocardial infarction |
| 09/06/2000 | EP1032556A1 Pharmaceutically active compounds and methods of use |
| 09/05/2000 | US6114325 1,2-di-substituted benzene-carboxamide derivative, hair growth promoter and external composition for skin using the same |
| 08/30/2000 | EP1030852A1 Oxazolidinone derivatives and pharmaceutical compositions |
| 08/30/2000 | EP1030662A2 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
| 08/30/2000 | CN1265109A Thiazolobenzoheterocycles, prepn. and medicines containing same |
| 08/29/2000 | US6110922 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 08/23/2000 | EP1029859A1 N,N'-Disubstituted unsymmetrical cyclic urea and its use in therapy |
| 08/16/2000 | EP1027336A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 08/16/2000 | EP1027042A1 Inhibitors of farnesyl protein transferase |
| 08/15/2000 | US6103715 Compounds that bind to the dopamine d4 receptor and their use as anxiolytic agents, treatment for schizophrenia, and drug screening; side effect reductioon |
| 08/15/2000 | US6103459 Lack delivered element-to-carbon bonds to reduce carbon contamination in films produced by vapor deposition; electroconductive polymers; metal complexes of the compounds; di-aza-, phospha-and/or arsa-butadiene type compounds |
| 08/09/2000 | EP1025092A2 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate |
| 08/09/2000 | EP1024811A1 Novel benzodiazepine derivatives as antiarrhythmic agents |
| 08/08/2000 | US6100395 Reductive alkylation of secondary amines with hydrosilane |
| 08/08/2000 | US6100277 Retroviral protease inhibitor combinations |
| 08/08/2000 | US6100254 1-benzyl,3-(p-hydroxybenzyl)-5-(p-hydroxyphenyl),7-chloro-1,4 -benzodiazepin-2-one; administering to treat cancer, and diseases caused abnormal nmda channel regulation |
| 08/03/2000 | WO2000044730A1 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 08/03/2000 | WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 08/03/2000 | WO2000028947A3 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 08/03/2000 | DE19903126A1 New sulphur substituted sulphonylaminocarboxylic acid N-arylamide derivatives used for treating e.g. cardiovascular diseases and atherosclerosis |
| 08/03/2000 | CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2356267A1 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 08/02/2000 | EP1023072A1 Analgesic compositions |
| 08/01/2000 | US6096885 Exhibit agonist activity for cck-a receptors thereby enabling them to modulate the hormones gastrin and cholecystokinin in mammals. |
| 08/01/2000 | US6096741 Oxime derivatives, hydrazone derivatives and use thereof |
| 08/01/2000 | US6096735 Benzoheterocyclic derivatives |
| 07/27/2000 | WO2000042849A1 COMPLEX OF RAS-FARNESYLTRANSFERASE INHIBITOR AND SULFOBUTYLETHER-7-β-CYCLODEXTRIN OR 2-HYDROXYPROPYL-β-CYCLODEXTRIN AND METHOD |
| 07/26/2000 | EP1021418A1 Substituted 2,3-benzodiazepin-4-ones and the use thereof |
| 07/26/2000 | EP1021190A1 Novel amide derivatives |
| 07/25/2000 | CA2169115C 1-¬2-(substituted vinyl)|-5h-2,3-benzodiazepine derivatives |
| 07/20/2000 | WO2000042040A1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 07/20/2000 | WO2000041992A1 Reductive alkylation of secondary amines with hydrosilane |
| 07/20/2000 | CA2359569A1 Reductive alkylation of secondary amines with hydrosilane |
| 07/19/2000 | EP1019383A2 Process for the aminocarbonylation of benzazepines and benzodiazepines |
| 07/19/2000 | EP1019058A1 Pharmaceutical suspension comprising nevirapine hemihydrate |
| 07/19/2000 | EP1018880A1 2-methyl-thieno-benzodiazepine formulation |
| 07/12/2000 | CN1054380C Condensed cyclic compounds and their use |
| 07/06/2000 | WO2000039110A1 Homopiperazine derivatives as selective emopamil inhibitors |
| 07/06/2000 | WO2000039105A1 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders |
| 07/06/2000 | WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/06/2000 | WO2000038618A2 SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 07/06/2000 | CA2347671A1 Succinoylamino benzodiazepines as inhibitors of a.beta. protein production |
| 07/05/2000 | EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 06/22/2000 | WO2000006620A3 Polymerization of olefins |
| 06/21/2000 | EP1010696A1 Method of preparing Oxoquazepam |
| 06/21/2000 | EP1009739A2 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 06/21/2000 | CN1257071A Process for preparation of ketoquazepan |
| 06/14/2000 | EP1008592A2 Cyclic amide derivatives which inhibit cathepsin K |
| 06/14/2000 | CN1053438C Benzodiazepin-2-one derivatives, process for their prepn. and pharmaceutical composition containing them |
| 06/14/2000 | CA2284961A1 Method of preparing oxoquazepam |
| 06/13/2000 | US6075018 Tranquilizers |
| 06/06/2000 | US6071903 2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids |
| 06/06/2000 | US6071895 Polar-substituted hydrocarbons |
| 06/02/2000 | WO2000031073A1 Benzoxazole derivatives and drugs containing the same as the active ingredient |
| 06/02/2000 | CA2351446A1 Benzoxazole derivatives and medicaments comprising said derivatives as active ingredient |
| 05/31/2000 | EP0635016B1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof |
| 05/25/2000 | WO2000028947A2 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 05/25/2000 | CA2349919A1 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 05/24/2000 | CN1253954A Heterocyclic alkoxyl amine as regulator in controlled free radical polymerization method |
| 05/18/2000 | WO2000004892A3 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/17/2000 | EP1000936A1 Novel hexahydro-1,4-diazepine derivatives or salts thereof |
| 05/17/2000 | EP1000067A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 05/17/2000 | EP1000062A1 Tricyclic vasopressin agonists |
| 05/17/2000 | CN1253555A Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 05/17/2000 | CN1253554A Heterocyclic compounds and their use for inhibiting 'beta'-amyloid peptide |